A. Menarini Asia-Pacific Holdings Pte. Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
28 Pages - GLDATA54237
$250.00

Summary

A. Menarini Asia-Pacific Holdings Pte. Ltd. (A. Menarini Asia-Pacific), formerly Invida Group Pte Ltd, a subsidiary of A. Menarini Industrie Farmaceutiche Riunite Srl is a biopharmaceutical company that develops consumer health care products. The company operates through its divisions including R and D, biotech and diagnostics. Its R and D division access to global network of research and development infrastructure. A. Menarini Asia-Pacific’s biotech division develops and manufactures bio-pharmaceuticals, using mammalian cells and microbial production systems. The company’s diagnostics division provides technological solutions for healthcare professionals. It serves in the area of diabetes, autoimmunity, cell pathology, hemoglobin analysis, urine analysis, and others. A. Menarini Asia-Pacific is headquartered in Singapore.

A. Menarini Asia-Pacific Holdings Pte. Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
A. Menarini Asia-Pacific Holdings Pte. Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
A. Menarini Asia-Pacific Holdings Pte. Ltd., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
A. Menarini Asia-Pacific Holdings Pte. Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
A. Menarini Asia-Pacific Holdings Pte. Ltd., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
A. Menarini Asia-Pacific Holdings Pte. Ltd., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
A. Menarini Asia-Pacific Holdings Pte. Ltd., Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Invida Acquires Dermatology And Primary Care Product Portfolios From Shalaks Pharma For US$20 Million 10
Partnerships 12
Moberg Pharma Extends Distribution Agreement With Menarini 12
Moberg Extends Distribution Agreement With Menarini For Kerasal Nail 13
Menarini Enters Into Commercialization Agreement With Gilead Sciences For Ranexa 14
Invida Group Enters Into Agreement With F. Hoffmann-La Roche 16
Licensing Agreements 18
Menarini Enters into Licensing Agreement with Mitsubishi Tanabe Pharma for Spedra 18
Faes Farma And Invida Enter Into Licensing Agreement For Bilastine 19
Orexo Enters Into Licensing Agreement With Invida Group For Abstral 20
Invida Group Enters Into Licensing Agreement With Amdipharm 21
Acquisition 22
Menarini Group Acquires Invida 22
Invida Acquires 70% Stake In Mugi Labs 24
A. Menarini Asia-Pacific Holdings Pte. Ltd. - Key Competitors 25
Key Employees 26
Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
A. Menarini Asia-Pacific Holdings Pte. Ltd., Pharmaceuticals & Healthcare, Key Facts 1
A. Menarini Asia-Pacific Holdings Pte. Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
A. Menarini Asia-Pacific Holdings Pte. Ltd., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
A. Menarini Asia-Pacific Holdings Pte. Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
A. Menarini Asia-Pacific Holdings Pte. Ltd., Deals By Therapy Area, 2010 to YTD 2016 8
A. Menarini Asia-Pacific Holdings Pte. Ltd., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Invida Acquires Dermatology And Primary Care Product Portfolios From Shalaks Pharma For US$20 Million 10
Moberg Pharma Extends Distribution Agreement With Menarini 12
Moberg Extends Distribution Agreement With Menarini For Kerasal Nail 13
Menarini Enters Into Commercialization Agreement With Gilead Sciences For Ranexa 14
Invida Group Enters Into Agreement With F. Hoffmann-La Roche 16
Menarini Enters into Licensing Agreement with Mitsubishi Tanabe Pharma for Spedra 18
Faes Farma And Invida Enter Into Licensing Agreement For Bilastine 19
Orexo Enters Into Licensing Agreement With Invida Group For Abstral 20
Invida Group Enters Into Licensing Agreement With Amdipharm 21
Menarini Group Acquires Invida 22
Invida Acquires 70% Stake In Mugi Labs 24
A. Menarini Asia-Pacific Holdings Pte. Ltd., Key Competitors 25
A. Menarini Asia-Pacific Holdings Pte. Ltd., Key Employees 26
A. Menarini Asia-Pacific Holdings Pte. Ltd., Subsidiaries 27

List of Figures
A. Menarini Asia-Pacific Holdings Pte. Ltd., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
A. Menarini Asia-Pacific Holdings Pte. Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
A. Menarini Asia-Pacific Holdings Pte. Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
A. Menarini Asia-Pacific Holdings Pte. Ltd., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
A. Menarini Asia-Pacific Holdings Pte. Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
A. Menarini Asia-Pacific Holdings Pte. Ltd., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
A. Menarini Asia-Pacific Holdings Pte. Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
A. Menarini Asia-Pacific Holdings Pte. Ltd., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838